Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) COO John Gallagher sold 430 shares of Trupanion stock in a transaction on Wednesday, January 28th. The stock was sold at an average price of $31.67, for a total transaction of $13,618.10. Following the transaction, the chief operating officer owned 31,861 shares in the company, valued at $1,009,037.87. This represents a 1.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Trupanion Trading Up 2.4%
NASDAQ:TRUP opened at $32.17 on Friday. Trupanion, Inc. has a one year low of $30.85 and a one year high of $57.88. The business has a fifty day moving average price of $35.64 and a 200-day moving average price of $41.48. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of 89.36 and a beta of 1.58. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.71 and a quick ratio of 1.71.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The company had revenue of $366.92 million for the quarter, compared to the consensus estimate of $361.58 million. During the same period in the prior year, the firm posted $0.03 EPS. The business's revenue for the quarter was up 12.0% on a year-over-year basis. Sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.
Analyst Ratings Changes
Several equities analysts have weighed in on the stock. Cantor Fitzgerald lowered their price target on shares of Trupanion from $50.00 to $42.00 and set a "neutral" rating on the stock in a report on Wednesday, January 14th. Piper Sandler lowered their target price on shares of Trupanion from $67.00 to $60.00 and set an "overweight" rating on the stock in a research note on Friday, December 19th. Wall Street Zen downgraded shares of Trupanion from a "buy" rating to a "hold" rating in a report on Saturday, December 6th. Weiss Ratings reissued a "sell (d+)" rating on shares of Trupanion in a report on Monday, December 29th. Finally, Stifel Nicolaus dropped their price objective on Trupanion from $42.00 to $38.00 and set a "hold" rating for the company in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $50.00.
Check Out Our Latest Stock Report on Trupanion
Institutional Trading of Trupanion
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Federated Hermes Inc. purchased a new stake in Trupanion in the 3rd quarter worth $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Trupanion in the third quarter worth about $39,000. Nisa Investment Advisors LLC increased its holdings in shares of Trupanion by 44.1% in the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider's stock worth $54,000 after purchasing an additional 300 shares during the last quarter. Kelleher Financial Advisors purchased a new stake in shares of Trupanion in the third quarter worth about $74,000. Finally, GAMMA Investing LLC boosted its stake in Trupanion by 30.1% during the second quarter. GAMMA Investing LLC now owns 2,133 shares of the financial services provider's stock valued at $118,000 after buying an additional 494 shares during the last quarter.
About Trupanion
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
